Examkin

Question

Difficulty: Very hardGynecologic Infections

Correlate each complex clinical presentation of a lower reproductive tract infection with its most appropriate, evidence-based management strategy.

  • A 23-year-old presents with multiple exquisitely tender, deep vulvar ulcerations featuring a purulent base, accompanied by fluctuant inguinal lymph nodes. Microscopic evaluation of the exudate shows Gram-negative coccobacilli arranged in parallel chains.Administer a single systemic dose of ceftriaxone or azithromycin to eradicate the infection.
  • A 29-year-old is evaluated for a slowly expanding, painless, beefy-red vulvar ulceration that is highly vascular and bleeds easily. Tissue microscopy demonstrates bipolar-staining bacterial inclusions enclosed within large mononuclear macrophages.Prescribe prolonged antimicrobial therapy with azithromycin, continuing for a minimum of three weeks or until complete re-epithelialization occurs.
  • A 26-year-old returns to the clinic with persistent mucopurulent cervicitis and intermenstrual bleeding, having recently failed empiric single-dose and seven-day antibiotic courses. Molecular testing isolates a fastidious, cell-wall-lacking pathogen known for widespread macrolide resistance.Initiate a sequential two-stage antimicrobial regimen, utilizing doxycycline followed immediately by moxifloxacin.
  • A 21-year-old presents with a unilateral, painful conglomerate of enlarged inguinal lymph nodes separated by a groove. She notes a transient, painless genital papule that resolved without intervention several weeks ago.Provide a definitive twenty-one-day course of doxycycline, and consider needle aspiration of the fluctuant lymphadenopathy to prevent rupture.

Answer

The correct pairings appropriately match the painful ulcers of Chancroid to single-dose therapy, the beefy-red painless ulcers of Granuloma inguinale to prolonged >3-week therapy, the macrolide-resistant Mycoplasma genitalium cervicitis to sequential two-stage therapy, and the buboes of Lymphogranuloma venereum to a 21-day tetracycline course.
The correct pairings accurately reflect current therapeutic guidelines for specific, highly tested genital infections. Chancroid is highly susceptible and requires only single-dose therapy. Granuloma inguinale necessitates prolonged therapy until complete tissue healing is achieved. Mycoplasma genitalium cervicitis, due to its concerning resistance patterns, strictly requires a resistance-guided or two-stage approach utilizing a tetracycline followed by a fluoroquinolone. Lymphogranuloma venereum requires a specific 21-day tetracycline course along with possible mechanical drainage of suppurative lymph nodes.

Step-by-Step Solution

1
Differentiate the etiology of the genital lesions based on pain, morphology, and lymphadenopathy.
Painful ulcers with fluctuant nodes indicate Chancroid; painless beefy-red vascular ulcers indicate Granuloma inguinale; transient painless ulcers followed by painful coalesced buboes indicate Lymphogranuloma venereum.
Pain is the primary differentiating clinical feature for genital ulcers, significantly narrowing the differential diagnosis before incorporating microscopic findings.
2
Correlate specific microscopic findings and clinical history with the causative pathogens.
Parallel bacterial chains identify Haemophilus ducreyi; macrophage inclusions identify Klebsiella granulomatis; persistent cervicitis failing standard therapy identifies Mycoplasma genitalium.
Precise pathogen identification is required because each of these organisms has distinct pharmacokinetic requirements for eradication.
3
Assign the guideline-concordant antimicrobial regimen to each identified organism.
Chancroid receives single-dose therapy; Granuloma inguinale receives >3 weeks of therapy; Mycoplasma genitalium receives sequential doxycycline then moxifloxacin; LGV receives exactly 21 days of doxycycline.
Matching the exact temporal and sequential pharmacological requirements ensures definitive tissue healing and mitigates antimicrobial resistance.

Key Concept

Distinctive clinical presentations, microscopic findings, and precise antimicrobial regimens for classic and emerging lower genital tract infections.
Rate this question

Topics

Gynecologic Infections

More questions from this topic